SCHEMBL19504448

SCHEMBL19504448

CN1CC2(C1)CN(CC(F)(F)F)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17624330 0.84 TSHR (0.33)
SCHEMBL27305612 0.84 CYP3A4 (0.37)
SCHEMBL17624099 0.81 OPRM1 (0.35)
SCHEMBL22182595 0.81 HIF1A (0.36)
SCHEMBL27306428 0.81 CYP3A4 (0.35)
SCHEMBL25792495 0.79
SCHEMBL25094062 0.78 CRHBP (0.31)
SCHEMBL19498552 0.74 CYP3A4 (0.33)
SCHEMBL17611220 0.73 TSHR (0.32)
SCHEMBL18702127 0.72 EPHX2 (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230203007-A1 PYRIDINYLACETAMIDE DERIVATIVES AS SODIUM CHANNEL ACTIVATORS X-CHEM GLOBAL HQ 2023-06-29 US disclosed
US-20170305922-A1 CARM1 INHIBITORS AND USES THEREOF Epizyme, Inc. (US) 2017-10-26 US disclosed